Article
Reassessment and reclassification of variants of unknown significance in patients with cardiomyopathy in a specialist department.
Journal of medical genetics - 26 Feb 2025
Horgan Sinead, Kotwal Huafrin, Malan Antonetta, Sekhri Neha, Lopes Luis R
Abstract excerpt
BACKGROUND: The utility of diagnostic genetic testing in cardiomyopathy has grown significantly, due to the discovery of novel genes and greater awareness among healthcare professionals. However, a substantial proportion of cases (around 50%) yield no causative genetic variants or have variants of unknown significance (VUS), limiting their use in clinical management and familial screening. The increase in data...
Topics
Join the communities discussing this publication.
